Taiwan FDA registration 49faea8069b432270b2c47249820711d
DiaSys Total Protein (Urine/CSF) Test (Non-Sterile)
TW: 德賽總蛋白質(尿液/腦脊髓液)試劑 (未滅菌)
Taiwan·Risk Class 1·MD·DIASYS DIAGNOSTIC SYSTEMS GMBH·Registered Jul 31, 2020 – Jul 31, 2025ExpiredRegistration details
- Analysis ID
- 49faea8069b432270b2c47249820711d
- License Form
- Ministry of Health Medical Device Import No. 021807
- Customs Code
- DHA09402180700
Company information
- Manufacturer
- DIASYS DIAGNOSTIC SYSTEMS GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- MEDITRUST MEDICAL SERVICE & CONSULTANT CO., LTD.
Product details
- Intended Use
- Limited to the first level identification range of the Measures for the Administration of Medical Devices "Protein (Chemical Separation Method) Test System (A.1630)".
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1630 Protein (Chemical Separation) Test System
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jul 31, 2020
- Expiry Date
- Jul 31, 2025
About this record
Access comprehensive regulatory information for DiaSys Total Protein (Urine/CSF) Test (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 49faea8069b432270b2c47249820711d and manufactured by DIASYS DIAGNOSTIC SYSTEMS GMBH. The authorized representative in Taiwan is MEDITRUST MEDICAL SERVICE & CONSULTANT CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices